TSW
CHE icon

Thompson Siegel & Walmsley’s Chemed CHE Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-26
Closed -$4K – 865
2016
Q4 		$4K Buy
+26
New +$3.82K ﹤0.01% 700
2014
Q1 		– Sell
-110,339
Closed -$8.45M – 660
2013
Q4 		$8.45M Sell
110,339
-68,419
-38% -$5.04M 0.2% 206
2013
Q3 		$12.8M Sell
178,758
-37,729
-17% -$2.68M 0.28% 156
2013
Q2 		$15.7M Buy
+216,487
New +$15.9M 0.34% 127

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Thompson Siegel & Walmsley's CHE Position: Q1 2017 in Review

Thompson Siegel & Walmsley sold out of Chemed (CHE) in Q1 2017, closing a stake of 26 shares — an estimated $4K sold.

Thompson Siegel & Walmsley first reported a position in CHE in Q2 2013 and held it in 4 quarters. The position peaked at $15.7M in Q2 2013. 250 funds tracked by Wall St. Rank hold CHE as of Q1 2017.

  • Thompson Siegel & Walmsley reported no remaining Chemed position as of Q1 2017 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 26 Chemed shares in Q1 2017, an estimated $4K.
  • Thompson Siegel & Walmsley first reported a position in Chemed in Q2 2013 and held it in 4 quarters.
  • Thompson Siegel & Walmsley's Chemed position peaked at $15.7M in Q2 2013.
  • 250 funds tracked by Wall St. Rank held Chemed as of Q1 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2017, filed 15 May 2017.